Blueprint Medicines Corp

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC BPMC

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/14/2025

Shares

215,946

Value ($000)

27,680

Weight

0.0%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/14/2025	27,680	0.0%	215,946	6/30/2025
2025 Q1	5/19/2025	21,633	0.0%	244,411	3/31/2025
2024 Q4	2/14/2025	20,928	0.0%	239,946	12/31/2024
2024 Q3	11/14/2024	21,082	0.0%	227,911	9/30/2024
2024 Q2	8/14/2024	32,536	0.0%	301,873	6/30/2024
2024 Q1	5/15/2024	22,256	0.0%	234,615	3/31/2024
2023 Q4	2/14/2024	22,061	0.0%	239,173	12/31/2023
2023 Q3	11/13/2023	12,163	0.0%	242,192	9/30/2023
2023 Q2	8/11/2023	11,353	0.0%	252,349	6/30/2023
2023 Q1	5/15/2023	11,353	0.0%	252,349	3/31/2023
2022 Q4	2/14/2023	11,464	0.0%	261,685	12/31/2022
2022 Q3	11/14/2022	17,690	0.0%	268,475	9/30/2022
2022 Q2	8/12/2022	14,161	0.0%	280,362	6/30/2022
2022 Q1	5/16/2022	15,330	0.0%	239,976	3/31/2022
2021 Q4	2/14/2022	25,129	0.0%	234,607	12/31/2021
2021 Q3	11/15/2021	26,842	0.0%	261,081	9/30/2021
2021 Q2	8/16/2021	24,837	0.0%	282,369	6/30/2021
2021 Q1	5/14/2021	25,101	0.0%	258,165	3/31/2021
2020 Q4	3/1/2021	37,907	0.0%	338,002	12/31/2020
2020 Q3	11/13/2020	27,899	0.0%	300,962	9/30/2020
2020 Q2	8/14/2020	21,779	0.0%	279,212	6/30/2020
2020 Q1	5/15/2020	5,390	0.0%	92,173	3/31/2020
2019 Q4	2/14/2020	11,043	0.0%	137,852	12/31/2019